Rapid Communication - Journal of Orthopedic Surgery and Rehabilitation (2023) Volume 7, Issue 5
Polypharmacy and Medication Optimization.
Department of Orthopaedic Surgery
- *Corresponding Author:
- Harper Liu
Department of Orthopaedic Surgery
Beth Israel Deaconess Medical Centre
Received:28-Aug-2023,Manuscript No.AAOSR-23-115161; Editor assigned:31-Aug-2023,PreQC No. AAOSR-23- 115161(PQ); Reviewed:14-Sept-2023,QC No. AAOSR-23- 115161; Revised:20-Sept-2023,Manuscript No. AAOSR-23-115161(R); Published:27-Sept-2023,DOI: 10.35841/ aaosr-7.5.166
Citation: Liu H. Polypharmacy and Medication Optimization.J Ortho Sur Reh.2023;7(5):166
The concurrent use of several medications by one person is known as polypharmacy, and it has grown to be a widespread and complicated problem in contemporary medicine. The unintended implications of polypharmacy, such as negative drug interactions, dosage errors, and impaired patient safety, have generated serious concerns even though drugs are crucial instruments in managing a wide range of medical diseases. An overview of polypharmacy, its causes, and the necessity of medication optimisation as a pro-active, patient-centered strategy to reduce related risks are provided in this abstract. The complicated healthcare requirements of people, especially those with numerous chronic illnesses and comorbidities, can result in polypharmacy..
The concurrent use of several drugs, each with specific indications, dosages, and potential adverse effects, results in a complex and dynamic therapeutic environment that poses difficulties for patients and healthcare professionals alike. Polypharmacy is becoming more common, especially among the older population. The multiple effects of polypharmacy on patient outcomes, healthcare expenses, and the standard of care are examined in the abstract. A increasing older population, improvements in medicine, and the fragmented nature of healthcare delivery are all contributing causes to polypharmacy. Having a thorough understanding of these elements is necessary for creating efficient drug optimisation techniques. A higher risk of adverse drug reactions, hospitalizations, and a lower quality of life are all connected to polypharmacy. The abstract covers the difficulties in managing complicated pharmaceutical regimens faced by healthcare professionals. A proactive and patient-focused strategy for addressing polypharmacy is medication optimisation..
Strategies including medication reconciliation, prescribing, and collaborative decision-making are highlighted in the abstract. Medication optimisation must include encouraging patients to take an active role in managing their medications. In order to achieve the best results, the abstract discusses the significance of patient education, medication adherence, and communication. A concerted effort across healthcare systems is needed to optimize medication, including the use of electronic health information, interprofessional cooperation, and prescribing guidelines. In conclusion, polypharmacy presents a serious challenge in modern healthcare, but medication optimisation offers a potentially effective remedy. Medication optimisation can assist in navigating the complexities of polypharmacy by focusing on patient safety, improved outcomes, and improved communication between patients and healthcare providers. This will make sure that medication regimens are streamlined, efficient, and in line with patient goals and preferences. This abstract emphasises how crucial it is to deal with polypharmacy and put drug optimisation methods in place to raise the standard of treatment and improve patient wellbeing. The practice known as polypharmacy, which is the concurrent use of several medications by one person, has emerged as a complex problem in modern medicine..
While pharmaceuticals have revolutionized how different medical diseases are managed, the unchecked growth of therapeutic alternatives and the more complicated needs of patients have resulted in polypharmacy's unforeseen side effects. These negative effects include a higher chance of medication errors, unfavorable drug interactions, decreased patient safety, and subpar therapeutic results. The necessity of medication optimisation has arisen as a proactive and patient-focused strategy to overcome the issues provided by polypharmacy as healthcare providers try to provide patient-centered care. The idea of polypharmacy has developed beyond a simple list of drugs; it now includes a complex understanding of how various drugs interact with one another, each with its own indications, dosages, and potential side effects. Patients who have various chronic diseases, comorbidities, and age-related changes in drug metabolism and tolerance add to the complexity of this already complex treatment environment. Polypharmacy is a phenomenon that affects a wide range of patient demographics and is not exclusive to any one demographic. It is especially important for the elderly, who frequently struggle with a variety of chronic diseases and are more likely to experience negative pharmacological side effects. Advances in medical knowledge, the proliferation of pharmaceutical alternatives, and the dynamics of contemporary healthcare systems all contribute to the prevalence of polypharmacy. The effects of polypharmacy go far beyond the field of medicine. It affects patient outcomes, healthcare expenses, the standard of treatment, and relationships between patients and providers. In order to create efficient strategies for medication optimisation, it is crucial to understand the complex effects of polypharmacy..
A special set of difficulties are presented to healthcare providers when managing polypharmacy. The risk of adverse drug events must be addressed, drug interactions must be recognized and minimized, medication adherence must be maintained, and treatment choices must be in line with the patient's overall health objectives and quality of life. A comprehensive and individualized strategy to drug management is necessary due to the complexity of polypharmacy. Medication optimisation is a pro-active approach to polypharmacy's difficulties. It places a strong emphasis on patient safety, better therapeutic results, and patients taking an active role in their own care. Medication reconciliation, stopping the prescription of hazardous or unnecessary prescriptions, patient and healthcare provider decision-sharing and thorough patient education are all examples of medication optimisation initiatives. This investigation of polypharmacy and medication optimisation aims to give readers a thorough knowledge of these ideas in relation to contemporary healthcare..
The complex nature of osteoporosis in the elderly calls for a strategy that goes beyond conventional ideas about bone health. A comprehensive examination of each person receiving geriatric care should take into account their cognitive ability, functional condition, diet, and medication use. The objective is to offer thorough care that is adapted to the unique requirements and vulnerabilities of elderly patients. A thorough geriatric assessment, fracture risk stratification, nutrition and supplementation, physical activity and functional exercise, fall prevention strategies, pharmacological interventions, and medication optimisation are just a few of the key topics covered in this investigation of osteoporosis prevention in the elderly. Healthcare professionals and researchers can strive towards a more efficient and individualized approach to osteoporosis prevention in the elderly by tackling these aspects collectively. Elderly osteoporosis prevention is a complex task that calls for an in-depth knowledge of the ageing process, a patient-centred, all-encompassing approach, and the incorporation of evidence-based methods that cover not only bone health but also the more comprehensive aspects of geriatric well-being. In order to lessen the burden of osteoporosis and enhance the quality of life for the aged population, this investigation intends to shed light on the crucial role that geriatric considerations and creative approaches play..
It emphasises how crucial it is to deal with polypharmacy's problems and put medication optimisation measures in place in order to improve patient safety, improve treatment outcomes, and give patients more control over their own medication management. Healthcare providers and patients can collaborate to create safer, more efficient, and more pleasant healthcare experiences by negotiating the complexity of polypharmacy with a patient-centred approach.
- Wiggins AJ, Grandhi RK, Schneider DK, et al.Risk of secondary injury in younger athletes after anterior cruciate ligament reconstruction: A systematic review and meta-analysis Am J Sports Med. 2016 ;44(7):1861-76.
- Grassi A, Carulli C, Innocenti M, et al.New trends in anterior cruciate ligament reconstruction: A systematic review of national surveys of the last 5 years Joints. 2018;6(03):177-87.
- Wilk KE, Arrigo CA.Rehabilitation principles of the anterior cruciate ligament reconstructed knee: Twelve steps for successful progression and return to play.Clin Sports Med. 2017;36(1):189-232
- Sonnery-Cottet B, Saithna A, Quelard B, et al.Arthrogenic muscle inhibition after ACL reconstruction: A scoping review of the efficacy of interventionsBr J Sports Med.2019;53(5):289-98.
- Welling W, Benjaminse A, Lemmink K, et al. Progressive strength training restores quadriceps and hamstring muscle strength within 7 months after ACL reconstruction in amateur male soccer playersPhys Ther Sport. 2019;40:10-8..